nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—PDE5A—pulmonary artery—lung cancer	0.0361	0.194	CbGeAlD
Pentoxifylline—NT5E—mammary gland—lung cancer	0.014	0.0755	CbGeAlD
Pentoxifylline—PDE4A—mammary gland—lung cancer	0.0107	0.0576	CbGeAlD
Pentoxifylline—NT5E—respiratory system—lung cancer	0.00936	0.0503	CbGeAlD
Pentoxifylline—NT5E—epithelium—lung cancer	0.00782	0.042	CbGeAlD
Pentoxifylline—NT5E—bronchus—lung cancer	0.0077	0.0414	CbGeAlD
Pentoxifylline—NT5E—trachea—lung cancer	0.00691	0.0372	CbGeAlD
Pentoxifylline—ADORA2B—bronchus—lung cancer	0.00659	0.0354	CbGeAlD
Pentoxifylline—NT5E—cardiac atrium—lung cancer	0.0065	0.0349	CbGeAlD
Pentoxifylline—PDE5A—respiratory system—lung cancer	0.00607	0.0326	CbGeAlD
Pentoxifylline—ADORA2B—trachea—lung cancer	0.00592	0.0318	CbGeAlD
Pentoxifylline—NT5E—bone marrow—lung cancer	0.00548	0.0295	CbGeAlD
Pentoxifylline—Caffeine—PIK3CB—lung cancer	0.00518	0.282	CrCbGaD
Pentoxifylline—Caffeine—PIK3CD—lung cancer	0.00518	0.282	CrCbGaD
Pentoxifylline—PDE5A—epithelium—lung cancer	0.00507	0.0273	CbGeAlD
Pentoxifylline—NT5E—lung—lung cancer	0.00497	0.0267	CbGeAlD
Pentoxifylline—PDE4B—respiratory system—lung cancer	0.00426	0.0229	CbGeAlD
Pentoxifylline—ADORA2B—lung—lung cancer	0.00425	0.0229	CbGeAlD
Pentoxifylline—Caffeine—PIK3CA—lung cancer	0.00401	0.218	CrCbGaD
Pentoxifylline—ADORA1—cardiac atrium—lung cancer	0.004	0.0215	CbGeAlD
Pentoxifylline—PDE4A—lung—lung cancer	0.00379	0.0204	CbGeAlD
Pentoxifylline—PDE4B—bronchus—lung cancer	0.0035	0.0188	CbGeAlD
Pentoxifylline—NT5E—lymph node—lung cancer	0.0034	0.0183	CbGeAlD
Pentoxifylline—PDE5A—lung—lung cancer	0.00322	0.0173	CbGeAlD
Pentoxifylline—PDE4B—trachea—lung cancer	0.00315	0.0169	CbGeAlD
Pentoxifylline—ADORA1—lung—lung cancer	0.00306	0.0164	CbGeAlD
Pentoxifylline—PDE4B—cardiac atrium—lung cancer	0.00296	0.0159	CbGeAlD
Pentoxifylline—CYP1A2—respiratory system—lung cancer	0.00262	0.0141	CbGeAlD
Pentoxifylline—PDE4A—lymph node—lung cancer	0.00259	0.0139	CbGeAlD
Pentoxifylline—PDE4B—bone marrow—lung cancer	0.0025	0.0134	CbGeAlD
Pentoxifylline—PDE4B—lung—lung cancer	0.00226	0.0122	CbGeAlD
Pentoxifylline—PDE5A—lymph node—lung cancer	0.00221	0.0119	CbGeAlD
Pentoxifylline—ADORA1—lymph node—lung cancer	0.00209	0.0112	CbGeAlD
Pentoxifylline—Theobromine—CYP2E1—lung cancer	0.00174	0.0946	CrCbGaD
Pentoxifylline—PDE4B—lymph node—lung cancer	0.00155	0.00831	CbGeAlD
Pentoxifylline—CYP1A2—lung—lung cancer	0.00139	0.00746	CbGeAlD
Pentoxifylline—Caffeine—CYP2E1—lung cancer	0.000893	0.0486	CrCbGaD
Pentoxifylline—Caffeine—CYP1A1—lung cancer	0.000881	0.048	CrCbGaD
Pentoxifylline—Caffeine—ABCB1—lung cancer	0.000468	0.0255	CrCbGaD
Pentoxifylline—Dizziness—Vinorelbine—lung cancer	0.000383	0.000774	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Paclitaxel—lung cancer	0.000381	0.00077	CcSEcCtD
Pentoxifylline—Tachycardia—Paclitaxel—lung cancer	0.00038	0.000768	CcSEcCtD
Pentoxifylline—Anorexia—Etoposide—lung cancer	0.000378	0.000765	CcSEcCtD
Pentoxifylline—Skin disorder—Paclitaxel—lung cancer	0.000378	0.000764	CcSEcCtD
Pentoxifylline—Body temperature increased—Irinotecan—lung cancer	0.000377	0.000763	CcSEcCtD
Pentoxifylline—Abdominal pain—Irinotecan—lung cancer	0.000377	0.000763	CcSEcCtD
Pentoxifylline—Decreased appetite—Cisplatin—lung cancer	0.000377	0.000761	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Paclitaxel—lung cancer	0.000376	0.000761	CcSEcCtD
Pentoxifylline—Anaemia—Docetaxel—lung cancer	0.000374	0.000755	CcSEcCtD
Pentoxifylline—Infestation—Methotrexate—lung cancer	0.000373	0.000754	CcSEcCtD
Pentoxifylline—Drowsiness—Methotrexate—lung cancer	0.000373	0.000754	CcSEcCtD
Pentoxifylline—Infestation NOS—Methotrexate—lung cancer	0.000373	0.000754	CcSEcCtD
Pentoxifylline—Anorexia—Paclitaxel—lung cancer	0.000371	0.00075	CcSEcCtD
Pentoxifylline—Hypotension—Etoposide—lung cancer	0.000371	0.00075	CcSEcCtD
Pentoxifylline—Vomiting—Vinorelbine—lung cancer	0.000368	0.000744	CcSEcCtD
Pentoxifylline—Body temperature increased—Gemcitabine—lung cancer	0.000368	0.000743	CcSEcCtD
Pentoxifylline—Rash—Vinorelbine—lung cancer	0.000365	0.000738	CcSEcCtD
Pentoxifylline—Dermatitis—Vinorelbine—lung cancer	0.000365	0.000737	CcSEcCtD
Pentoxifylline—Abdominal distension—Doxorubicin—lung cancer	0.000365	0.000737	CcSEcCtD
Pentoxifylline—Hypotension—Paclitaxel—lung cancer	0.000364	0.000735	CcSEcCtD
Pentoxifylline—Headache—Vinorelbine—lung cancer	0.000363	0.000733	CcSEcCtD
Pentoxifylline—Conjunctivitis—Methotrexate—lung cancer	0.000362	0.000733	CcSEcCtD
Pentoxifylline—Leukopenia—Docetaxel—lung cancer	0.000362	0.000731	CcSEcCtD
Pentoxifylline—Sweating—Methotrexate—lung cancer	0.000357	0.000723	CcSEcCtD
Pentoxifylline—Palpitations—Docetaxel—lung cancer	0.000357	0.000722	CcSEcCtD
Pentoxifylline—Feeling abnormal—Cisplatin—lung cancer	0.000357	0.000722	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000355	0.000717	CcSEcCtD
Pentoxifylline—Dyspnoea—Etoposide—lung cancer	0.000354	0.000715	CcSEcCtD
Pentoxifylline—Somnolence—Etoposide—lung cancer	0.000353	0.000713	CcSEcCtD
Pentoxifylline—Angina pectoris—Doxorubicin—lung cancer	0.000353	0.000713	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Methotrexate—lung cancer	0.000353	0.000713	CcSEcCtD
Pentoxifylline—Insomnia—Paclitaxel—lung cancer	0.000352	0.000712	CcSEcCtD
Pentoxifylline—Epistaxis—Methotrexate—lung cancer	0.000352	0.000711	CcSEcCtD
Pentoxifylline—Hypersensitivity—Irinotecan—lung cancer	0.000352	0.000711	CcSEcCtD
Pentoxifylline—Convulsion—Docetaxel—lung cancer	0.00035	0.000708	CcSEcCtD
Pentoxifylline—Hypertension—Docetaxel—lung cancer	0.000349	0.000706	CcSEcCtD
Pentoxifylline—Dyspnoea—Paclitaxel—lung cancer	0.000347	0.000702	CcSEcCtD
Pentoxifylline—Somnolence—Paclitaxel—lung cancer	0.000346	0.0007	CcSEcCtD
Pentoxifylline—Decreased appetite—Etoposide—lung cancer	0.000345	0.000698	CcSEcCtD
Pentoxifylline—Myalgia—Docetaxel—lung cancer	0.000344	0.000696	CcSEcCtD
Pentoxifylline—Chest pain—Docetaxel—lung cancer	0.000344	0.000696	CcSEcCtD
Pentoxifylline—Pancytopenia—Doxorubicin—lung cancer	0.000344	0.000695	CcSEcCtD
Pentoxifylline—Nausea—Vinorelbine—lung cancer	0.000344	0.000695	CcSEcCtD
Pentoxifylline—Dyspepsia—Paclitaxel—lung cancer	0.000343	0.000693	CcSEcCtD
Pentoxifylline—Body temperature increased—Cisplatin—lung cancer	0.000343	0.000692	CcSEcCtD
Pentoxifylline—Asthenia—Irinotecan—lung cancer	0.000342	0.000692	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000342	0.000691	CcSEcCtD
Pentoxifylline—Constipation—Etoposide—lung cancer	0.00034	0.000686	CcSEcCtD
Pentoxifylline—Decreased appetite—Paclitaxel—lung cancer	0.000338	0.000684	CcSEcCtD
Pentoxifylline—Dry mouth—Docetaxel—lung cancer	0.000337	0.00068	CcSEcCtD
Pentoxifylline—Haemoglobin—Methotrexate—lung cancer	0.000336	0.00068	CcSEcCtD
Pentoxifylline—Hepatitis—Methotrexate—lung cancer	0.000335	0.000677	CcSEcCtD
Pentoxifylline—Haemorrhage—Methotrexate—lung cancer	0.000335	0.000677	CcSEcCtD
Pentoxifylline—Asthenia—Gemcitabine—lung cancer	0.000334	0.000674	CcSEcCtD
Pentoxifylline—Constipation—Paclitaxel—lung cancer	0.000333	0.000673	CcSEcCtD
Pentoxifylline—Confusional state—Docetaxel—lung cancer	0.000333	0.000672	CcSEcCtD
Pentoxifylline—Oedema—Docetaxel—lung cancer	0.00033	0.000667	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Docetaxel—lung cancer	0.00033	0.000667	CcSEcCtD
Pentoxifylline—Pruritus—Gemcitabine—lung cancer	0.000329	0.000665	CcSEcCtD
Pentoxifylline—Infection—Docetaxel—lung cancer	0.000328	0.000663	CcSEcCtD
Pentoxifylline—Feeling abnormal—Etoposide—lung cancer	0.000327	0.000661	CcSEcCtD
Pentoxifylline—Diarrhoea—Irinotecan—lung cancer	0.000327	0.00066	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Etoposide—lung cancer	0.000325	0.000656	CcSEcCtD
Pentoxifylline—Shock—Docetaxel—lung cancer	0.000325	0.000656	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Docetaxel—lung cancer	0.000323	0.000653	CcSEcCtD
Pentoxifylline—Infestation NOS—Doxorubicin—lung cancer	0.000323	0.000653	CcSEcCtD
Pentoxifylline—Drowsiness—Doxorubicin—lung cancer	0.000323	0.000653	CcSEcCtD
Pentoxifylline—Infestation—Doxorubicin—lung cancer	0.000323	0.000653	CcSEcCtD
Pentoxifylline—Tachycardia—Docetaxel—lung cancer	0.000322	0.000651	CcSEcCtD
Pentoxifylline—Feeling abnormal—Paclitaxel—lung cancer	0.000321	0.000648	CcSEcCtD
Pentoxifylline—Skin disorder—Docetaxel—lung cancer	0.00032	0.000648	CcSEcCtD
Pentoxifylline—Hypersensitivity—Cisplatin—lung cancer	0.000319	0.000645	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Paclitaxel—lung cancer	0.000318	0.000643	CcSEcCtD
Pentoxifylline—Diarrhoea—Gemcitabine—lung cancer	0.000318	0.000643	CcSEcCtD
Pentoxifylline—Dizziness—Irinotecan—lung cancer	0.000316	0.000638	CcSEcCtD
Pentoxifylline—Urticaria—Etoposide—lung cancer	0.000315	0.000638	CcSEcCtD
Pentoxifylline—Jaundice—Doxorubicin—lung cancer	0.000315	0.000636	CcSEcCtD
Pentoxifylline—Anorexia—Docetaxel—lung cancer	0.000315	0.000636	CcSEcCtD
Pentoxifylline—Abdominal pain—Etoposide—lung cancer	0.000314	0.000634	CcSEcCtD
Pentoxifylline—Body temperature increased—Etoposide—lung cancer	0.000314	0.000634	CcSEcCtD
Pentoxifylline—Conjunctivitis—Doxorubicin—lung cancer	0.000314	0.000634	CcSEcCtD
Pentoxifylline—Asthenia—Cisplatin—lung cancer	0.000311	0.000628	CcSEcCtD
Pentoxifylline—Sweating—Doxorubicin—lung cancer	0.00031	0.000626	CcSEcCtD
Pentoxifylline—Urticaria—Paclitaxel—lung cancer	0.000309	0.000625	CcSEcCtD
Pentoxifylline—Hypotension—Docetaxel—lung cancer	0.000308	0.000623	CcSEcCtD
Pentoxifylline—Body temperature increased—Paclitaxel—lung cancer	0.000308	0.000622	CcSEcCtD
Pentoxifylline—Abdominal pain—Paclitaxel—lung cancer	0.000308	0.000622	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Doxorubicin—lung cancer	0.000305	0.000617	CcSEcCtD
Pentoxifylline—Epistaxis—Doxorubicin—lung cancer	0.000305	0.000616	CcSEcCtD
Pentoxifylline—Vomiting—Irinotecan—lung cancer	0.000303	0.000613	CcSEcCtD
Pentoxifylline—Immune system disorder—Methotrexate—lung cancer	0.000302	0.000611	CcSEcCtD
Pentoxifylline—Rash—Irinotecan—lung cancer	0.000301	0.000608	CcSEcCtD
Pentoxifylline—Dermatitis—Irinotecan—lung cancer	0.000301	0.000608	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000301	0.000608	CcSEcCtD
Pentoxifylline—Headache—Irinotecan—lung cancer	0.000299	0.000604	CcSEcCtD
Pentoxifylline—Insomnia—Docetaxel—lung cancer	0.000298	0.000603	CcSEcCtD
Pentoxifylline—Diarrhoea—Cisplatin—lung cancer	0.000297	0.000599	CcSEcCtD
Pentoxifylline—Vomiting—Gemcitabine—lung cancer	0.000296	0.000598	CcSEcCtD
Pentoxifylline—Dyspnoea—Docetaxel—lung cancer	0.000294	0.000595	CcSEcCtD
Pentoxifylline—Somnolence—Docetaxel—lung cancer	0.000293	0.000593	CcSEcCtD
Pentoxifylline—Rash—Gemcitabine—lung cancer	0.000293	0.000593	CcSEcCtD
Pentoxifylline—Dermatitis—Gemcitabine—lung cancer	0.000293	0.000592	CcSEcCtD
Pentoxifylline—Hypersensitivity—Etoposide—lung cancer	0.000293	0.000591	CcSEcCtD
Pentoxifylline—Erythema—Methotrexate—lung cancer	0.000291	0.000589	CcSEcCtD
Pentoxifylline—Haemoglobin—Doxorubicin—lung cancer	0.000291	0.000589	CcSEcCtD
Pentoxifylline—Headache—Gemcitabine—lung cancer	0.000291	0.000589	CcSEcCtD
Pentoxifylline—Dyspepsia—Docetaxel—lung cancer	0.00029	0.000587	CcSEcCtD
Pentoxifylline—Hepatitis—Doxorubicin—lung cancer	0.00029	0.000586	CcSEcCtD
Pentoxifylline—Haemorrhage—Doxorubicin—lung cancer	0.00029	0.000586	CcSEcCtD
Pentoxifylline—Decreased appetite—Docetaxel—lung cancer	0.000287	0.00058	CcSEcCtD
Pentoxifylline—Hypersensitivity—Paclitaxel—lung cancer	0.000287	0.00058	CcSEcCtD
Pentoxifylline—Dysgeusia—Methotrexate—lung cancer	0.000285	0.000577	CcSEcCtD
Pentoxifylline—Asthenia—Etoposide—lung cancer	0.000285	0.000576	CcSEcCtD
Pentoxifylline—Nausea—Irinotecan—lung cancer	0.000284	0.000573	CcSEcCtD
Pentoxifylline—Constipation—Docetaxel—lung cancer	0.000282	0.00057	CcSEcCtD
Pentoxifylline—Back pain—Methotrexate—lung cancer	0.000282	0.00057	CcSEcCtD
Pentoxifylline—Pruritus—Etoposide—lung cancer	0.000281	0.000568	CcSEcCtD
Pentoxifylline—Asthenia—Paclitaxel—lung cancer	0.000279	0.000565	CcSEcCtD
Pentoxifylline—Nausea—Gemcitabine—lung cancer	0.000276	0.000558	CcSEcCtD
Pentoxifylline—Vomiting—Cisplatin—lung cancer	0.000276	0.000557	CcSEcCtD
Pentoxifylline—Pruritus—Paclitaxel—lung cancer	0.000275	0.000557	CcSEcCtD
Pentoxifylline—Vision blurred—Methotrexate—lung cancer	0.000275	0.000555	CcSEcCtD
Pentoxifylline—Rash—Cisplatin—lung cancer	0.000273	0.000552	CcSEcCtD
Pentoxifylline—Dermatitis—Cisplatin—lung cancer	0.000273	0.000552	CcSEcCtD
Pentoxifylline—Feeling abnormal—Docetaxel—lung cancer	0.000272	0.00055	CcSEcCtD
Pentoxifylline—Diarrhoea—Etoposide—lung cancer	0.000272	0.000549	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Methotrexate—lung cancer	0.00027	0.000546	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Docetaxel—lung cancer	0.00027	0.000545	CcSEcCtD
Pentoxifylline—Anaemia—Methotrexate—lung cancer	0.000269	0.000544	CcSEcCtD
Pentoxifylline—Flushing—Doxorubicin—lung cancer	0.000269	0.000544	CcSEcCtD
Pentoxifylline—Diarrhoea—Paclitaxel—lung cancer	0.000266	0.000538	CcSEcCtD
Pentoxifylline—Malaise—Methotrexate—lung cancer	0.000263	0.000531	CcSEcCtD
Pentoxifylline—Dizziness—Etoposide—lung cancer	0.000263	0.000531	CcSEcCtD
Pentoxifylline—Immune system disorder—Doxorubicin—lung cancer	0.000262	0.000529	CcSEcCtD
Pentoxifylline—Abdominal pain—Docetaxel—lung cancer	0.000261	0.000527	CcSEcCtD
Pentoxifylline—Body temperature increased—Docetaxel—lung cancer	0.000261	0.000527	CcSEcCtD
Pentoxifylline—Leukopenia—Methotrexate—lung cancer	0.000261	0.000527	CcSEcCtD
Pentoxifylline—Arrhythmia—Doxorubicin—lung cancer	0.000259	0.000523	CcSEcCtD
Pentoxifylline—Dizziness—Paclitaxel—lung cancer	0.000257	0.00052	CcSEcCtD
Pentoxifylline—Nausea—Cisplatin—lung cancer	0.000257	0.00052	CcSEcCtD
Pentoxifylline—Convulsion—Methotrexate—lung cancer	0.000252	0.00051	CcSEcCtD
Pentoxifylline—Vomiting—Etoposide—lung cancer	0.000252	0.00051	CcSEcCtD
Pentoxifylline—Erythema—Doxorubicin—lung cancer	0.000252	0.00051	CcSEcCtD
Pentoxifylline—Rash—Etoposide—lung cancer	0.00025	0.000506	CcSEcCtD
Pentoxifylline—Dermatitis—Etoposide—lung cancer	0.00025	0.000506	CcSEcCtD
Pentoxifylline—Headache—Etoposide—lung cancer	0.000249	0.000503	CcSEcCtD
Pentoxifylline—Flatulence—Doxorubicin—lung cancer	0.000249	0.000503	CcSEcCtD
Pentoxifylline—Myalgia—Methotrexate—lung cancer	0.000248	0.000501	CcSEcCtD
Pentoxifylline—Chest pain—Methotrexate—lung cancer	0.000248	0.000501	CcSEcCtD
Pentoxifylline—Tension—Doxorubicin—lung cancer	0.000248	0.0005	CcSEcCtD
Pentoxifylline—Vomiting—Paclitaxel—lung cancer	0.000248	0.0005	CcSEcCtD
Pentoxifylline—Dysgeusia—Doxorubicin—lung cancer	0.000247	0.000499	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000246	0.000498	CcSEcCtD
Pentoxifylline—Rash—Paclitaxel—lung cancer	0.000245	0.000496	CcSEcCtD
Pentoxifylline—Dermatitis—Paclitaxel—lung cancer	0.000245	0.000496	CcSEcCtD
Pentoxifylline—Discomfort—Methotrexate—lung cancer	0.000245	0.000495	CcSEcCtD
Pentoxifylline—Nervousness—Doxorubicin—lung cancer	0.000245	0.000495	CcSEcCtD
Pentoxifylline—Back pain—Doxorubicin—lung cancer	0.000244	0.000493	CcSEcCtD
Pentoxifylline—Headache—Paclitaxel—lung cancer	0.000244	0.000493	CcSEcCtD
Pentoxifylline—Hypersensitivity—Docetaxel—lung cancer	0.000243	0.000491	CcSEcCtD
Pentoxifylline—Muscle spasms—Doxorubicin—lung cancer	0.000243	0.00049	CcSEcCtD
Pentoxifylline—Confusional state—Methotrexate—lung cancer	0.00024	0.000485	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Methotrexate—lung cancer	0.000238	0.000481	CcSEcCtD
Pentoxifylline—Vision blurred—Doxorubicin—lung cancer	0.000238	0.000481	CcSEcCtD
Pentoxifylline—Asthenia—Docetaxel—lung cancer	0.000237	0.000479	CcSEcCtD
Pentoxifylline—Infection—Methotrexate—lung cancer	0.000236	0.000478	CcSEcCtD
Pentoxifylline—Nausea—Etoposide—lung cancer	0.000236	0.000477	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Doxorubicin—lung cancer	0.000234	0.000473	CcSEcCtD
Pentoxifylline—Pruritus—Docetaxel—lung cancer	0.000233	0.000472	CcSEcCtD
Pentoxifylline—Anaemia—Doxorubicin—lung cancer	0.000233	0.000471	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Methotrexate—lung cancer	0.000233	0.000471	CcSEcCtD
Pentoxifylline—Agitation—Doxorubicin—lung cancer	0.000232	0.000469	CcSEcCtD
Pentoxifylline—Nausea—Paclitaxel—lung cancer	0.000231	0.000467	CcSEcCtD
Pentoxifylline—Skin disorder—Methotrexate—lung cancer	0.000231	0.000467	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Methotrexate—lung cancer	0.00023	0.000465	CcSEcCtD
Pentoxifylline—Malaise—Doxorubicin—lung cancer	0.000228	0.00046	CcSEcCtD
Pentoxifylline—Anorexia—Methotrexate—lung cancer	0.000227	0.000458	CcSEcCtD
Pentoxifylline—Leukopenia—Doxorubicin—lung cancer	0.000226	0.000457	CcSEcCtD
Pentoxifylline—Diarrhoea—Docetaxel—lung cancer	0.000226	0.000456	CcSEcCtD
Pentoxifylline—Palpitations—Doxorubicin—lung cancer	0.000223	0.000451	CcSEcCtD
Pentoxifylline—Hypotension—Methotrexate—lung cancer	0.000222	0.000449	CcSEcCtD
Pentoxifylline—Convulsion—Doxorubicin—lung cancer	0.000219	0.000442	CcSEcCtD
Pentoxifylline—Dizziness—Docetaxel—lung cancer	0.000218	0.000441	CcSEcCtD
Pentoxifylline—Hypertension—Doxorubicin—lung cancer	0.000218	0.00044	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000217	0.000438	CcSEcCtD
Pentoxifylline—Insomnia—Methotrexate—lung cancer	0.000215	0.000435	CcSEcCtD
Pentoxifylline—Myalgia—Doxorubicin—lung cancer	0.000215	0.000434	CcSEcCtD
Pentoxifylline—Chest pain—Doxorubicin—lung cancer	0.000215	0.000434	CcSEcCtD
Pentoxifylline—Anxiety—Doxorubicin—lung cancer	0.000214	0.000433	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000213	0.000431	CcSEcCtD
Pentoxifylline—Discomfort—Doxorubicin—lung cancer	0.000212	0.000429	CcSEcCtD
Pentoxifylline—Dyspnoea—Methotrexate—lung cancer	0.000212	0.000429	CcSEcCtD
Pentoxifylline—Somnolence—Methotrexate—lung cancer	0.000211	0.000427	CcSEcCtD
Pentoxifylline—Dry mouth—Doxorubicin—lung cancer	0.00021	0.000425	CcSEcCtD
Pentoxifylline—Vomiting—Docetaxel—lung cancer	0.00021	0.000424	CcSEcCtD
Pentoxifylline—Dyspepsia—Methotrexate—lung cancer	0.000209	0.000423	CcSEcCtD
Pentoxifylline—Rash—Docetaxel—lung cancer	0.000208	0.000421	CcSEcCtD
Pentoxifylline—Dermatitis—Docetaxel—lung cancer	0.000208	0.00042	CcSEcCtD
Pentoxifylline—Confusional state—Doxorubicin—lung cancer	0.000208	0.00042	CcSEcCtD
Pentoxifylline—Decreased appetite—Methotrexate—lung cancer	0.000207	0.000418	CcSEcCtD
Pentoxifylline—Headache—Docetaxel—lung cancer	0.000207	0.000418	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Doxorubicin—lung cancer	0.000206	0.000416	CcSEcCtD
Pentoxifylline—Oedema—Doxorubicin—lung cancer	0.000206	0.000416	CcSEcCtD
Pentoxifylline—Infection—Doxorubicin—lung cancer	0.000205	0.000414	CcSEcCtD
Pentoxifylline—Shock—Doxorubicin—lung cancer	0.000203	0.00041	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Doxorubicin—lung cancer	0.000202	0.000408	CcSEcCtD
Pentoxifylline—Tachycardia—Doxorubicin—lung cancer	0.000201	0.000406	CcSEcCtD
Pentoxifylline—Skin disorder—Doxorubicin—lung cancer	0.0002	0.000404	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Doxorubicin—lung cancer	0.000199	0.000402	CcSEcCtD
Pentoxifylline—Anorexia—Doxorubicin—lung cancer	0.000196	0.000397	CcSEcCtD
Pentoxifylline—Nausea—Docetaxel—lung cancer	0.000196	0.000396	CcSEcCtD
Pentoxifylline—Feeling abnormal—Methotrexate—lung cancer	0.000196	0.000396	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Methotrexate—lung cancer	0.000194	0.000393	CcSEcCtD
Pentoxifylline—Hypotension—Doxorubicin—lung cancer	0.000192	0.000389	CcSEcCtD
Pentoxifylline—Urticaria—Methotrexate—lung cancer	0.000189	0.000382	CcSEcCtD
Pentoxifylline—Abdominal pain—Methotrexate—lung cancer	0.000188	0.00038	CcSEcCtD
Pentoxifylline—Body temperature increased—Methotrexate—lung cancer	0.000188	0.00038	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000188	0.000379	CcSEcCtD
Pentoxifylline—Insomnia—Doxorubicin—lung cancer	0.000186	0.000376	CcSEcCtD
Pentoxifylline—Dyspnoea—Doxorubicin—lung cancer	0.000184	0.000371	CcSEcCtD
Pentoxifylline—Somnolence—Doxorubicin—lung cancer	0.000183	0.00037	CcSEcCtD
Pentoxifylline—Dyspepsia—Doxorubicin—lung cancer	0.000181	0.000366	CcSEcCtD
Pentoxifylline—Decreased appetite—Doxorubicin—lung cancer	0.000179	0.000362	CcSEcCtD
Pentoxifylline—Constipation—Doxorubicin—lung cancer	0.000176	0.000356	CcSEcCtD
Pentoxifylline—Hypersensitivity—Methotrexate—lung cancer	0.000175	0.000354	CcSEcCtD
Pentoxifylline—Asthenia—Methotrexate—lung cancer	0.000171	0.000345	CcSEcCtD
Pentoxifylline—Feeling abnormal—Doxorubicin—lung cancer	0.00017	0.000343	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Doxorubicin—lung cancer	0.000168	0.00034	CcSEcCtD
Pentoxifylline—Pruritus—Methotrexate—lung cancer	0.000168	0.00034	CcSEcCtD
Pentoxifylline—Urticaria—Doxorubicin—lung cancer	0.000164	0.000331	CcSEcCtD
Pentoxifylline—Body temperature increased—Doxorubicin—lung cancer	0.000163	0.000329	CcSEcCtD
Pentoxifylline—Abdominal pain—Doxorubicin—lung cancer	0.000163	0.000329	CcSEcCtD
Pentoxifylline—Diarrhoea—Methotrexate—lung cancer	0.000163	0.000329	CcSEcCtD
Pentoxifylline—Dizziness—Methotrexate—lung cancer	0.000157	0.000318	CcSEcCtD
Pentoxifylline—Hypersensitivity—Doxorubicin—lung cancer	0.000152	0.000307	CcSEcCtD
Pentoxifylline—Vomiting—Methotrexate—lung cancer	0.000151	0.000306	CcSEcCtD
Pentoxifylline—Rash—Methotrexate—lung cancer	0.00015	0.000303	CcSEcCtD
Pentoxifylline—Dermatitis—Methotrexate—lung cancer	0.00015	0.000303	CcSEcCtD
Pentoxifylline—Headache—Methotrexate—lung cancer	0.000149	0.000301	CcSEcCtD
Pentoxifylline—Asthenia—Doxorubicin—lung cancer	0.000148	0.000299	CcSEcCtD
Pentoxifylline—Pruritus—Doxorubicin—lung cancer	0.000146	0.000294	CcSEcCtD
Pentoxifylline—Nausea—Methotrexate—lung cancer	0.000141	0.000286	CcSEcCtD
Pentoxifylline—Diarrhoea—Doxorubicin—lung cancer	0.000141	0.000285	CcSEcCtD
Pentoxifylline—Dizziness—Doxorubicin—lung cancer	0.000136	0.000275	CcSEcCtD
Pentoxifylline—Vomiting—Doxorubicin—lung cancer	0.000131	0.000265	CcSEcCtD
Pentoxifylline—Rash—Doxorubicin—lung cancer	0.00013	0.000262	CcSEcCtD
Pentoxifylline—Dermatitis—Doxorubicin—lung cancer	0.00013	0.000262	CcSEcCtD
Pentoxifylline—Headache—Doxorubicin—lung cancer	0.000129	0.000261	CcSEcCtD
Pentoxifylline—Nausea—Doxorubicin—lung cancer	0.000122	0.000247	CcSEcCtD
Pentoxifylline—ADORA2B—Signaling Pathways—MDM2—lung cancer	3.8e-05	0.000126	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—RAF1—lung cancer	3.78e-05	0.000126	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP2A7—lung cancer	3.78e-05	0.000126	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL2—lung cancer	3.77e-05	0.000125	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—KRAS—lung cancer	3.77e-05	0.000125	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL6R—lung cancer	3.76e-05	0.000125	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TERT—lung cancer	3.76e-05	0.000125	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CREBBP—lung cancer	3.76e-05	0.000125	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ERBB2—lung cancer	3.74e-05	0.000124	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—EGFR—lung cancer	3.74e-05	0.000124	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SDC4—lung cancer	3.7e-05	0.000123	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MTOR—lung cancer	3.69e-05	0.000123	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PIK3CB—lung cancer	3.69e-05	0.000123	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—EGFR—lung cancer	3.69e-05	0.000123	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FGFR1—lung cancer	3.65e-05	0.000121	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MAP2K1—lung cancer	3.63e-05	0.000121	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CD—lung cancer	3.6e-05	0.00012	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HIF1A—lung cancer	3.59e-05	0.000119	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MAP2K1—lung cancer	3.59e-05	0.000119	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—PIK3CA—lung cancer	3.57e-05	0.000119	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CD—lung cancer	3.56e-05	0.000118	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CXCL8—lung cancer	3.55e-05	0.000118	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—KRAS—lung cancer	3.53e-05	0.000117	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—PIK3CA—lung cancer	3.53e-05	0.000117	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—HRAS—lung cancer	3.53e-05	0.000117	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—KRAS—lung cancer	3.49e-05	0.000116	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—APOA1—lung cancer	3.47e-05	0.000115	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—PIK3CA—lung cancer	3.46e-05	0.000115	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MDM2—lung cancer	3.45e-05	0.000115	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—KDR—lung cancer	3.44e-05	0.000114	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—RAF1—lung cancer	3.44e-05	0.000114	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—AKT1—lung cancer	3.43e-05	0.000114	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ERBB2—lung cancer	3.4e-05	0.000113	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CASP3—lung cancer	3.4e-05	0.000113	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL2—lung cancer	3.39e-05	0.000113	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL6—lung cancer	3.38e-05	0.000112	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTA3—lung cancer	3.37e-05	0.000112	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—RRM1—lung cancer	3.37e-05	0.000112	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MTOR—lung cancer	3.36e-05	0.000112	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PIK3CB—lung cancer	3.36e-05	0.000112	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCND1—lung cancer	3.31e-05	0.00011	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—JUN—lung cancer	3.3e-05	0.00011	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—PIK3CA—lung cancer	3.24e-05	0.000108	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MDM2—lung cancer	3.23e-05	0.000107	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CXCL8—lung cancer	3.22e-05	0.000107	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—RAF1—lung cancer	3.22e-05	0.000107	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MMP9—lung cancer	3.21e-05	0.000107	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—PIK3CA—lung cancer	3.2e-05	0.000106	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—HRAS—lung cancer	3.2e-05	0.000106	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CDKN1A—lung cancer	3.2e-05	0.000106	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PTEN—lung cancer	3.19e-05	0.000106	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MDM2—lung cancer	3.19e-05	0.000106	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ERBB2—lung cancer	3.18e-05	0.000106	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—RAF1—lung cancer	3.18e-05	0.000106	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—B4GALT5—lung cancer	3.17e-05	0.000105	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—APC—lung cancer	3.17e-05	0.000105	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—KIT—lung cancer	3.17e-05	0.000105	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CG—lung cancer	3.17e-05	0.000105	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—NRAS—lung cancer	3.17e-05	0.000105	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ERBB2—lung cancer	3.15e-05	0.000105	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CB—lung cancer	3.14e-05	0.000104	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MTOR—lung cancer	3.14e-05	0.000104	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EGF—lung cancer	3.13e-05	0.000104	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—AKT1—lung cancer	3.11e-05	0.000104	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—AKT1—lung cancer	3.11e-05	0.000104	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MTOR—lung cancer	3.1e-05	0.000103	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CB—lung cancer	3.1e-05	0.000103	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CASP3—lung cancer	3.09e-05	0.000103	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTA4—lung cancer	3.08e-05	0.000102	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL2—lung cancer	3.08e-05	0.000102	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL6—lung cancer	3.07e-05	0.000102	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EP300—lung cancer	3.04e-05	0.000101	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—MAPK3—lung cancer	3.03e-05	0.000101	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CXCL8—lung cancer	3.02e-05	0.0001	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—POMC—lung cancer	3.01e-05	0.0001	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	3.01e-05	0.0001	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCND1—lung cancer	3e-05	9.98e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTA2—lung cancer	3e-05	9.98e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—HRAS—lung cancer	3e-05	9.97e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—JUN—lung cancer	3e-05	9.96e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CXCL8—lung cancer	2.98e-05	9.91e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—BRAF—lung cancer	2.98e-05	9.89e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—HRAS—lung cancer	2.96e-05	9.85e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SRC—lung cancer	2.96e-05	9.84e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL6R—lung cancer	2.94e-05	9.77e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CREBBP—lung cancer	2.94e-05	9.75e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—AKT1—lung cancer	2.92e-05	9.69e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MMP9—lung cancer	2.92e-05	9.69e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CDKN1A—lung cancer	2.91e-05	9.66e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PTEN—lung cancer	2.9e-05	9.64e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTA1—lung cancer	2.9e-05	9.63e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CASP3—lung cancer	2.89e-05	9.6e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL2—lung cancer	2.89e-05	9.59e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—EGFR—lung cancer	2.88e-05	9.59e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—VEGFA—lung cancer	2.88e-05	9.58e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—AKT1—lung cancer	2.88e-05	9.58e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL6—lung cancer	2.87e-05	9.54e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ABCC3—lung cancer	2.87e-05	9.52e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—STAT3—lung cancer	2.86e-05	9.49e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CASP3—lung cancer	2.86e-05	9.49e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL2—lung cancer	2.85e-05	9.48e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NRAS—lung cancer	2.85e-05	9.47e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL6—lung cancer	2.84e-05	9.43e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—AKT1—lung cancer	2.83e-05	9.4e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCND1—lung cancer	2.81e-05	9.35e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—JUN—lung cancer	2.81e-05	9.33e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MAP2K1—lung cancer	2.8e-05	9.31e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CD—lung cancer	2.78e-05	9.25e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCND1—lung cancer	2.78e-05	9.24e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—AKR1C1—lung cancer	2.77e-05	9.22e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—JUN—lung cancer	2.77e-05	9.22e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EP300—lung cancer	2.76e-05	9.19e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PIK3CA—lung cancer	2.76e-05	9.16e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MMP9—lung cancer	2.73e-05	9.08e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MAPK3—lung cancer	2.73e-05	9.07e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—KRAS—lung cancer	2.72e-05	9.06e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CDKN1A—lung cancer	2.72e-05	9.04e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PTEN—lung cancer	2.71e-05	9.02e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MMP9—lung cancer	2.7e-05	8.97e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—UGT1A1—lung cancer	2.69e-05	8.95e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CDKN1A—lung cancer	2.69e-05	8.94e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SRC—lung cancer	2.69e-05	8.94e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PTEN—lung cancer	2.68e-05	8.92e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MYC—lung cancer	2.65e-05	8.82e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—AKT1—lung cancer	2.65e-05	8.8e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—VEGFA—lung cancer	2.62e-05	8.7e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—AKT1—lung cancer	2.62e-05	8.7e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GNG11—lung cancer	2.6e-05	8.63e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EGFR—lung cancer	2.6e-05	8.63e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—STAT3—lung cancer	2.59e-05	8.62e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EP300—lung cancer	2.59e-05	8.6e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NRAS—lung cancer	2.59e-05	8.6e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.58e-05	8.59e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EP300—lung cancer	2.56e-05	8.5e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SRC—lung cancer	2.52e-05	8.37e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PIK3CA—lung cancer	2.5e-05	8.32e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MDM2—lung cancer	2.49e-05	8.29e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SRC—lung cancer	2.49e-05	8.27e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—RAF1—lung cancer	2.48e-05	8.26e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MAPK3—lung cancer	2.48e-05	8.23e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ALDOA—lung cancer	2.47e-05	8.22e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ERBB2—lung cancer	2.46e-05	8.17e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—VEGFA—lung cancer	2.45e-05	8.15e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—KRAS—lung cancer	2.45e-05	8.15e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—STAT3—lung cancer	2.43e-05	8.07e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MTOR—lung cancer	2.43e-05	8.06e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CB—lung cancer	2.43e-05	8.06e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—VEGFA—lung cancer	2.42e-05	8.05e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NRAS—lung cancer	2.42e-05	8.05e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MYC—lung cancer	2.41e-05	8.01e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NCOA3—lung cancer	2.4e-05	7.98e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—STAT3—lung cancer	2.4e-05	7.97e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NRAS—lung cancer	2.39e-05	7.95e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.36e-05	7.84e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EGFR—lung cancer	2.36e-05	7.83e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ABCG2—lung cancer	2.34e-05	7.76e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ADCY1—lung cancer	2.34e-05	7.76e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CXCL8—lung cancer	2.33e-05	7.75e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MAPK3—lung cancer	2.32e-05	7.71e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HRAS—lung cancer	2.32e-05	7.7e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MAPK3—lung cancer	2.29e-05	7.62e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—HPGDS—lung cancer	2.29e-05	7.61e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ENO2—lung cancer	2.29e-05	7.61e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PPP2R1B—lung cancer	2.28e-05	7.56e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MYC—lung cancer	2.26e-05	7.5e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PIK3CA—lung cancer	2.25e-05	7.49e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—AKT1—lung cancer	2.25e-05	7.48e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.25e-05	7.46e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CASP3—lung cancer	2.23e-05	7.41e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MYC—lung cancer	2.23e-05	7.41e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL2—lung cancer	2.23e-05	7.4e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—KRAS—lung cancer	2.23e-05	7.4e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTT1—lung cancer	2.22e-05	7.38e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL6—lung cancer	2.22e-05	7.37e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EGFR—lung cancer	2.21e-05	7.33e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GCLC—lung cancer	2.2e-05	7.3e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP2A6—lung cancer	2.2e-05	7.3e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.19e-05	7.27e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EGFR—lung cancer	2.18e-05	7.25e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TP53—lung cancer	2.18e-05	7.24e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCND1—lung cancer	2.17e-05	7.22e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—JUN—lung cancer	2.17e-05	7.2e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MMP9—lung cancer	2.11e-05	7.01e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CDKN1A—lung cancer	2.1e-05	6.98e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PTEN—lung cancer	2.1e-05	6.97e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—KRAS—lung cancer	2.08e-05	6.93e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HRAS—lung cancer	2.08e-05	6.93e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ENO1—lung cancer	2.08e-05	6.92e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.07e-05	6.89e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—KRAS—lung cancer	2.06e-05	6.85e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.05e-05	6.8e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PIK3CA—lung cancer	2.05e-05	6.8e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—AKT1—lung cancer	2.04e-05	6.8e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EP300—lung cancer	2e-05	6.64e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL6—lung cancer	1.99e-05	6.63e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TP53—lung cancer	1.98e-05	6.58e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SRC—lung cancer	1.94e-05	6.46e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CA—lung cancer	1.92e-05	6.37e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—VEGFA—lung cancer	1.89e-05	6.29e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CA—lung cancer	1.89e-05	6.29e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HRAS—lung cancer	1.89e-05	6.29e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—STAT3—lung cancer	1.87e-05	6.23e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NRAS—lung cancer	1.87e-05	6.22e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP2E1—lung cancer	1.87e-05	6.21e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TP53—lung cancer	1.85e-05	6.16e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NQO1—lung cancer	1.85e-05	6.14e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—AKT1—lung cancer	1.84e-05	6.12e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TP53—lung cancer	1.83e-05	6.08e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL6—lung cancer	1.81e-05	6.02e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.81e-05	6.01e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.79e-05	5.95e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MAPK3—lung cancer	1.79e-05	5.95e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HRAS—lung cancer	1.77e-05	5.89e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HRAS—lung cancer	1.75e-05	5.82e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MYC—lung cancer	1.74e-05	5.79e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EGFR—lung cancer	1.7e-05	5.66e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL6—lung cancer	1.7e-05	5.64e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL6—lung cancer	1.68e-05	5.57e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AKT1—lung cancer	1.67e-05	5.55e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—STK11—lung cancer	1.66e-05	5.53e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—KRAS—lung cancer	1.61e-05	5.35e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AKT1—lung cancer	1.56e-05	5.2e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.56e-05	5.19e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AKT1—lung cancer	1.55e-05	5.14e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTP1—lung cancer	1.54e-05	5.12e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CAT—lung cancer	1.5e-05	4.98e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.49e-05	4.95e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CA—lung cancer	1.48e-05	4.91e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ABCB1—lung cancer	1.46e-05	4.84e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TYMS—lung cancer	1.43e-05	4.76e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TP53—lung cancer	1.43e-05	4.75e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTM1—lung cancer	1.42e-05	4.7e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HRAS—lung cancer	1.37e-05	4.55e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP1A1—lung cancer	1.34e-05	4.46e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ERCC2—lung cancer	1.33e-05	4.42e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL6—lung cancer	1.31e-05	4.35e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AKT1—lung cancer	1.21e-05	4.01e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—APOA1—lung cancer	1.15e-05	3.83e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.1e-05	3.66e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CG—lung cancer	1.05e-05	3.49e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—POMC—lung cancer	1e-05	3.32e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CREBBP—lung cancer	9.74e-06	3.24e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CD—lung cancer	9.24e-06	3.07e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ALB—lung cancer	9.12e-06	3.03e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CB—lung cancer	8.05e-06	2.68e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PTGS2—lung cancer	7.98e-06	2.65e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PTEN—lung cancer	6.96e-06	2.31e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—EP300—lung cancer	6.63e-06	2.21e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CA—lung cancer	4.91e-06	1.63e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—AKT1—lung cancer	4.01e-06	1.33e-05	CbGpPWpGaD
